Article Name Europe

France welcomes the first FLASH radiotherapy machine to treat patients

Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy. French medical technology company THERYQ, specializing in particle accelerators and radiotherapy systems, has provided Gustave Roussy's Department of Radiotherapy with the first FLASH clinical radiotherapy machine in France for treating superficial tumours.

13th July, 2023


ivWatch Technology Shows Exceptional Sensitivity in Wilhelmina Children's Hospital Study

Published in The Journal of Vascular Access (JVA), study shows company's patented patient monitoring system detects IV infiltrations and extravasations earlier than clinicians

12th July, 2023


Getinge recieves US FDA 510(k) clearance for Servo-air® Lite

Getinge announces clearance from the US FDA for Servo-air® Lite, a wall gas independent non-invasive mechanical ventilator.

10th July, 2023


IMed Consultancy Launches New UKRP-Focused Website for Medical Device Launches in the UK

IMed launches new UKRP resource to inform businesses after surge in demand for UKRP services

05th July, 2023


Translumina strengthens technology portfolio with acquisition of Blue Medical Devices in Netherlands

Giving access to a patented, innovative, and proven next-generation Drug Coated Balloon technology

04th July, 2023


FDA Approves ImageBiopsy Labs' AI Software for Comprehensive Long Leg Radiograph Measurements

- ImageBiopsy Lab announced it has received clearance from the United States Food and Drug Administration (FDA) for IB Lab LAMA, the first fully-automated radiological image processing software for geometric length and angle measurements of the lower limb on full leg X-rays. The company previously FDA-cleared its IB Lab KOALA Knee-Osteoarthritis Labeling Assistant and intends to expand to the US with further MSK-focused software solutions.

26th June, 2023


Medtronic Unveils New Data on MiniMed™ 780G System's Meal Dosing and Time in Range in Diverse User Group

Medtronic plc(opens new window) (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting glycemic goals, and individuals using a simplified meal announcement leveraging fixed carbohydrate amounts instead of exact carb calculations, found that the proprietary Meal Detection™ technology supported Time in Range outcomes that exceed consensus guidelines of 70 percent. Additionally, the system is helping reduce the percent of time spent in hyperglycemia in children and adults.

26th June, 2023


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer